Week 44 (30th Oct, 2017 to 05th Nov, 2017): IPRs Report
AIA Review | Filing Date | Petitioner | Respondent App | Respondent Patent | Tech Center |
---|---|---|---|---|---|
IPR2018-00125 | 10/30/2017 | Initiative for Medicines, Access & Knowledge (I-MAK), Inc. | 13738425 | 8633309 | 1600 |
IPR2018-00134 | 10/30/2017 | Ninebot (Tianjin) Technology Co. Ltd. | 13044487 | 8807250 | 3600 |
IPR2018-00136 | 10/30/2017 | Zscaler Inc. | 10388903 | 7203959 | 2100 |
IPR2018-00137 | 10/30/2017 | Zscaler Inc. | 10388903 | 7203959 | 2100 |
IPR2018-00138 | 10/31/2017 | Axis Communications AB | 11828842 | 8564661 | 2400 |
IPR2018-00139 | 10/31/2017 | The Heil Co. | 12274273 | 8146798 | 2800 |
IPR2018-00140 | 10/31/2017 | Axis Communications AB | 11828842 | 8564661 | 2400 |
IPR2018-00142 | 11/1/2017 | Freebit AS | 14272845 | 9398364 | 2600 |
IPR2018-00086 | 11/2/2017 | Pfizer, Inc. | 12886171 | 8545843 | 1600 |
IPR2018-00126 | 11/2/2017 | Initiative for Medicines, Access & Knowledge (I-MAK), Inc. | 13925078 | 9284342 | 1600 |
IPR2018-00129 | 11/2/2017 | Riot Games, Inc. | 8595323 | 5822523 | 2700 |
IPR2018-00130 | 11/2/2017 | Riot Games, Inc. | 8595323 | 5822523 | 2700 |
IPR2018-00131 | 11/2/2017 | Riot Games, Inc. | 9407371 | 6226686 | 2100 |
IPR2018-00132 | 11/2/2017 | Riot Games, Inc. | 9407371 | 6226686 | 2100 |
IPR2018-00143 | 11/2/2017 | Nevro Corporation | 11329907 | 7891085 | 3700 |
IPR2018-00146 | 11/2/2017 | Coriant (USA) Inc. | 13762717 | 9363012 | 2600 |
IPR2018-00147 | 11/2/2017 | Nevro Corporation | 13620099 | 8650747 | 3700 |
IPR2018-00141 | 11/3/2017 | Nevro Corp. | 13482504 | 8644933 | 3700 |
IPR2018-00148 | 11/3/2017 | NEVRO CORP. | 13013599 | 8646172 | 3700 |
IPR2018-00149 | 11/3/2017 | ARI Phoenix, Inc. | 10055800 | 6983196 | 2100 |
IPR2018-00150 | 11/3/2017 | InAuth, Inc. | 15075066 | 9559852 | 2400 |
No comments